The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, is urging industry stakeholders worldwide to focus on science and not geography, in a call for greater global collaboration
Cyrus Biotechnology, a Seattle-based biotech software company has announced the release of a novel antibody structure prediction software tool as part of its Cyrus Bench platform
Certara has announced that it will partner with the US Centers for Disease Control & Prevention (CDC) to strengthen the Agency’s death investigation and surveillance systems
Oxford Gene Technology (OGT), has announced that it is expanding its Cytocell operations with a move to a new facility in Cambridge, UK
Certara is aiming to increase the use of Model-informed Precision Dosing (MIPD) to help make individualised dosing more prevalent in clinics
The Pistoia Alliance has announced that it is launching the next phase of its blockchain project which aims to identify potential applications for the use of blockchain in the life sciences
Dotmatics and TetraScience recently announced a strategic partnership to bring R&D labs an improved relationship with their scientific data.
Kaia Health, has announced it has raised $10 million in a Series A round led by Balderton Capital to tackle some of the world’s most urgent health challenges, including a range of chronic conditions
A new report from the Pistoia Alliance finds that multi-disciplinary innovation, the implementation of new technologies, new approaches to research, the digitisation of R&D and healthcare, and academic contributions to biologics drug R&D are all key trends in the life sciences industry.
Drug development is facing change – both from technological pressures, such as the use of AI and machine learning, plus new regulations which are driving sweeping changes to the way electronic records are created and stored for clinical trials.
Robert Roe speaks with laboratory informatics software providers about the future of their software and the introduction of new technologies, such as AI and deep learning
Scientists are now beginning to use new technologies such as the internet of things (IoT), artificial intelligence (AI) and machine learning (ML) in their daily workflows.
In today’s world, where drug development integrates science and technology, consumer safety is paramount in the pharmaceutical industry.
